Vasovagal syncope is the most common cause of syncope across all age groups, accounting for approximately two-thirds of syncope diagnoses, and is mediated by a reflex causing inappropriate vasodilation and bradycardia triggered by prolonged standing, emotional stress, pain, or medical procedures. [1-2] The prognosis is benign, but recurrent episodes can impair quality of life and cause injury. [3]
1. History
- Prodrome: Ask about diaphoresis, warmth, nausea, pallor, lightheadedness, tunnel vision, or "odd abdominal sensation" preceding the event — these are hallmark features of VVS [3-4]
- Triggers: Prolonged standing, warm environments, emotional distress, fear, pain, blood draws/medical procedures, dehydration, fasting, alcohol [1][3]
- Situational variants: Cough, micturition, defecation, swallowing, laughing (classified as situational reflex syncope) [5]
- Position at onset: Standing or seated (VVS almost never occurs supine — supine syncope suggests cardiac etiology) [1][3]
- Duration of LOC: Typically <30 seconds; >60 seconds raises concern for seizure [5]
- Recovery: Rapid return to baseline, though fatigue is common post-event; confusion or postictal state suggests seizure [5]
- Frequency and chronicity: Recurrent episodes over >4 years with similar characteristics suggest low risk of cardiac etiology [5]
- Activity at time: After exertion (benign) vs. during exertion (concerning for cardiac) [5]
2. Alarm Features
Red flags that suggest a non-vasovagal, potentially life-threatening cause:
- Syncope during exertion or while supine [1][3]
- No prodrome / sudden LOC without warning [1-2]
- Associated chest pain, dyspnea, or palpitations preceding the event [2]
- Witnessed cyanosis during the episode [2]
- Family history of sudden cardiac death (<50 years) or inheritable cardiac conditions (Brugada, HCM, long QT) [1]
- Known structural heart disease, prior arrhythmia, or reduced EF [1]
- Abnormal ECG (new conduction disease, Brugada pattern, prolonged QT, pre-excitation) [6]
- SBP <90 mmHg or >180 mmHg at presentation [5]
- Persistent bradycardia or new murmur [5]
- GI bleeding signs (melena, hematemesis, rectal bleeding) [5]
- Age >60 with first episode and no clear trigger [1]
3. Medications
Contributors to syncope:
- Antihypertensives (especially alpha-blockers, vasodilators, diuretics)
- Nitrates, calcium channel blockers, ACE inhibitors
- Dopaminergic agents, opiates, antipsychotics, sedatives
- Tricyclic antidepressants, QT-prolonging drugs [5]
Treatments for recurrent VVS (per ACC/AHA/HRS 2017 guidelines): [1][3]
- Midodrine (alpha-agonist): Class IIa — 43% reduction in recurrence in meta-analysis; avoid in hypertension, HF, urinary retention [1][7]
- Fludrocortisone: Class IIb — mineralocorticoid for volume expansion; monitor potassium; best in younger patients with low-normal BP [1][3]
- Beta-blockers: Class IIb — might be reasonable in patients ≥42 years; RCTs have been largely negative; ESC guidelines rate as Class III (not indicated) [3][8]
- SSRIs (fluoxetine, paroxetine): Class IIb — weak evidence; fluoxetine showed benefit in network meta-analysis, particularly with concomitant anxiety [7-8]
- Reduce/discontinue hypotensive medications when appropriate: Class IIb [8]
Contraindicated/caution:
- Midodrine contraindicated in hypertension, HF, urinary retention [1]
- Fludrocortisone: avoid in HF; monitor K+ [1]
4. Diet
- Increased salt intake (Class IIb recommendation) and liberal fluid intake (2–3 L/day) to expand plasma volume, unless contraindicated (e.g., HF, CKD) [8]
- Avoid prolonged fasting, excessive alcohol, and large carbohydrate-heavy meals (postprandial hypotension)
- Caffeine in moderation may help some patients; no strong evidence
5. Review of Systems
- Cardiovascular: Chest pain, palpitations, dyspnea on exertion, exercise intolerance
- Neurologic: Headache, focal weakness, speech changes, seizure-like activity, postictal confusion, aura
- GI: Hematemesis, melena, hematochezia, abdominal pain
- Endocrine: Symptoms of hypoglycemia (tremor, diaphoresis, confusion)
- Psychiatric: Anxiety, panic attacks, hyperventilation, depression (psychogenic pseudosyncope)
- OB/GYN: Pregnancy status in women of childbearing age
6. Collateral History and Family History
- Witness account is critical: Observed pallor, diaphoresis, and brief LOC with rapid recovery support VVS; witnessed cyanosis or prolonged tonic-clonic activity suggests cardiac or seizure etiology [2][5]
- Family history: Sudden cardiac death <50 years, Brugada syndrome, HCM, long QT syndrome, arrhythmogenic right ventricular cardiomyopathy [1]
- Social context: Occupation (driving, operating machinery, heights), impact on quality of life, injury from falls
7. Risk Factors
- Young age (peak incidence in adolescents and young adults)
- Female sex (slightly more common)
- History of prior vasovagal episodes (frequent recurrence is typical)
- Anxiety, phobias (blood-injection-injury phobia)
- Dehydration, poor oral intake, prolonged standing
- Warm environments, crowded spaces
- Sleep deprivation
- Comorbidities increasing risk of syncope in general: cardiac disease, autonomic neuropathy (diabetes, Parkinson disease), anemia [5][9]
8. Differential Diagnosis
Cannot-miss diagnoses:
- Cardiac arrhythmia (VT, SVT, bradyarrhythmia, long QT, Brugada) — sudden onset, no prodrome, abnormal ECG [5]
- Structural heart disease (aortic stenosis, HCM, cardiac tamponade) — exertional syncope, murmur [5]
- Pulmonary embolism — dyspnea, tachycardia, pleuritic chest pain, risk factors for VTE [5]
- Aortic dissection — tearing chest/back pain, pulse differential, hypotension [5]
- Acute MI — chest pain, diaphoresis, ECG changes [5]
- Subarachnoid hemorrhage — thunderclap headache, meningismus
Important mimics:
- Orthostatic hypotension — positional, medication-related, autonomic failure; distinguished by orthostatic vitals [5]
- Seizure — LOC >60 seconds, tonic-clonic activity, tongue biting, postictal confusion, incontinence [5]
- POTS — HR increase ≥30 bpm on standing without BP drop; predominantly young women [3]
- Carotid sinus hypersensitivity — older adults, triggered by neck pressure [5]
- Psychogenic pseudosyncope — prolonged episodes, eyes closed, no hemodynamic changes [3]
- Hypoglycemia — diabetic patients on insulin/sulfonylureas; check glucose
9. Past Medical History
- Prior syncopal episodes (number, frequency, similarity to current event)
- Cardiac history: Ischemic heart disease, HF, arrhythmias, valvular disease, congenital heart disease — presence significantly increases likelihood of cardiac syncope [1]
- Neurologic history: Seizure disorder, stroke/TIA
- Autonomic disorders: Diabetes, Parkinson disease
- Psychiatric history: Anxiety, panic disorder, conversion disorder
- Surgical history: Pacemaker/ICD, cardiac surgery
- Pregnancy status
10. Physical Exam
Vital signs:
- Orthostatic blood pressure and heart rate — measure after 5 minutes supine, then at 1 and 3 minutes standing; SBP drop ≥20 mmHg or DBP drop ≥10 mmHg = orthostatic hypotension [5]
- Heart rate, rhythm, blood pressure in both arms
Focused exam:
- Cardiac: Rate, rhythm, murmurs (aortic stenosis, HCM — systolic murmur increasing with Valsalva), gallops, rubs, JVD [5]
- Neurologic: Mental status, cranial nerves, motor/sensory, speech, gait — focal deficits suggest stroke/TIA or post-syncopal head injury [5]
- Skin: Pallor, diaphoresis (consistent with VVS); cyanosis (concerning for cardiac)
- Rectal exam: If GI bleeding suspected
- Extremities: Peripheral pulses, edema, signs of DVT
Expected findings in VVS: Normal exam; patient may appear fatigued but neurologically intact with normal cardiac exam [1]
11. Lab Studies
Routine labs have low diagnostic yield and should be ordered based on clinical suspicion: [5]
- Fingerstick glucose — rule out hypoglycemia (obtain in all ED syncope patients)
- Pregnancy test (urine hCG) — all women of childbearing age
- CBC/hemoglobin — if GI bleeding or anemia suspected
- BMP — if dehydration, electrolyte abnormality, or renal disease suspected
- Troponin and BNP/NT-proBNP — if cardiac syncope suspected; elevated levels associated with higher risk of adverse outcomes [5]
- D-dimer — if PE suspected
- TSH — low yield acutely; consider in recurrent unexplained syncope
In classic VVS with clear trigger and prodrome, no labs may be necessary [4]
12. Imaging
- Imaging is seldom beneficial in the evaluation of syncope and should not be routinely ordered [5]
- Echocardiography: Only if suspected structural heart disease based on history, exam, or ECG (Class IIa for patients ≥60 with abnormal ECG or elevated BNP) [5]
- Head CT: Only if intracranial pathology suspected or concern for head trauma from the fall — not part of routine syncope workup [5]
- CT angiography of chest: Only if PE suspected [5]
- Carotid ultrasound: Only if focal neurologic findings present; syncope alone is not an indication [5]
13. Special Tests
Risk stratification scores:
- Canadian Syncope Risk Score (CSRS): Best validated tool; components include ECG findings, physician diagnosis, predisposition to vasovagal symptoms, heart disease history, SBP, and troponin; AUC 0.91 in validation. Very-low and low-risk patients had <1% rate of 30-day serious outcomes and zero deaths or ventricular arrhythmias [10]
- San Francisco Syncope Rule (SFSR): 5 risk factors (abnormal ECG, Hct <30%, HF history, dyspnea, SBP <90); sensitivity 87% but performed poorly on external validation [10-11]
- EGSYS score: Score <3 associated with low likelihood of cardiac syncope (LR 0.12–0.17) [2]
Tilt-table testing: Consider when initial evaluation does not clearly establish reflex syncope, orthostatic syncope, POTS, or psychogenic pseudosyncope; also useful for patient education on recognizing prodromes [5]
Carotid sinus massage: For patients >40 years with unexplained syncope compatible with reflex mechanism [5]
Prolonged ECG monitoring: If cardiac cause suspected and not identified on initial ECG; duration based on event frequency (implantable loop recorder for infrequent events) [5]
14. ECG
A 12-lead ECG should be obtained in all patients presenting with syncope (Class I recommendation). [5]
Findings suggesting cardiac syncope (dangerous patterns):
- Sustained or non-sustained VT
- Mobitz type II or complete heart block
- Sinus pause >3 seconds
- Bifascicular block or trifascicular block
- Brugada pattern (coved ST elevation in V1–V3)
- Prolonged QTc (>500 ms)
- Pre-excitation (delta wave — WPW)
- New ST changes or Q waves suggesting ischemia/infarction
- Epsilon waves (ARVC)
- Left axis deviation with conduction disease [6]
Expected ECG in VVS: Normal — a normal ECG combined with no history of heart disease makes cardiac syncope unlikely (LR 0.20) [2]
15. Assessment
- VVS is a clinical diagnosis made primarily on history: syncope precipitated by emotional distress, pain, prolonged standing, or medical settings, with typical prodromal autonomic symptoms (pallor, diaphoresis, nausea, warmth), brief LOC, and rapid recovery with post-event fatigue [3-4]
- No further testing is required when the clinical picture is classic [4]
- Atypical presentations in older adults: prodrome may be absent or attenuated, making differentiation from cardiac syncope more challenging [3]
- Severity spectrum: Ranges from rare isolated episodes to frequent recurrent syncope causing significant disability and injury
- Complications: Traumatic injury from falls (fractures, head injury, lacerations), driving accidents, impaired quality of life, anxiety about recurrence
The following table from the JAMA Rational Clinical Examination summarizes the likelihood ratios for clinical features distinguishing cardiac from vasovagal syncope:
16. Treatment Plan
Initial stabilization (ED):
- Supine positioning with legs elevated
- IV access if hemodynamically unstable; IV fluids for dehydration
- Continuous cardiac monitoring until cardiac cause excluded
- Treat any identified precipitant (pain, dehydration, bleeding)
First-line management (all patients) — Class I: [1][3]
- Patient education: Explain the diagnosis, benign prognosis, and natural history of remissions
- Trigger avoidance: Prolonged standing, warm environments, dehydration, alcohol, blood draws (when possible)
- Recognize prodrome: Instruct to sit or lie down immediately at onset of warning symptoms
Non-pharmacologic (recurrent VVS) — Class IIa: [3][8]
- Physical counter-pressure maneuvers: Leg crossing, squatting, isometric hand grip, abdominal contraction during prodrome (most effective in patients <60 years with sufficient prodrome)
- Increased salt and fluid intake (Class IIb) [8]
- Orthostatic training (tilt training): Uncertain benefit; RCTs have not shown sustained benefit (Class IIb) [1]
Pharmacologic (refractory recurrent VVS): [3][7-8]
- Midodrine 2.5–10 mg TID (Class IIa) — best evidence; 43% reduction in recurrence
- Fludrocortisone 0.1–0.2 mg daily (Class IIb) — monitor K+; best in young patients with low-normal BP
- Beta-blockers (Class IIb) — consider in patients ≥42 years; evidence is weak
- SSRIs (Class IIb) — limited evidence; consider if concomitant anxiety
- Reduce/stop hypotensive medications when appropriate (Class IIb)
Pacing (highly selected patients):
17. Disposition
Discharge criteria (low risk): [5][10]
- Classic VVS presentation with identifiable trigger and typical prodrome
- Normal ECG
- Normal vital signs (including orthostatics)
- No history of cardiac disease
- No concerning features on exam
- CSRS very-low or low-risk category (<1% 30-day serious outcome rate; zero deaths or ventricular arrhythmias in validation) [10]
Observation/admission criteria: [5]
- Syncope during exertion or while supine
- No prodrome / sudden LOC
- Associated chest pain, dyspnea, or palpitations
- Abnormal ECG
- Known structural heart disease or prior arrhythmia
- Family history of sudden cardiac death
- SBP <90 mmHg
- Significant injury from the event
- Persistent abnormal vital signs
- High-risk CSRS category (~20% 30-day serious outcome rate) [10]
Specialist consultation triggers:
- Cardiology: Suspected cardiac syncope, abnormal ECG, structural heart disease, recurrent unexplained syncope
- Neurology: Suspected seizure, focal neurologic deficits
- Electrophysiology: Recurrent syncope with documented asystole for pacemaker consideration
18. Follow Up / Return Precautions
Follow-up timing:
- Primary care follow-up within 1–2 weeks for uncomplicated VVS
- Earlier if recurrent episodes or new symptoms develop
- Cardiology referral for recurrent unexplained syncope or atypical features
Return precautions — instruct patients to return immediately for:
- Syncope during exercise or physical exertion
- Chest pain, palpitations, or shortness of breath
- Syncope without any warning/prodrome
- Recurrent episodes in short succession
- Prolonged LOC or confusion after the event
- New neurologic symptoms (weakness, speech difficulty, vision changes)
Patient counseling:
- VVS is benign with an excellent long-term prognosis [1]
- Recurrence is common but episodes often remit spontaneously over time
- Driving: Advise caution; specific restrictions vary by jurisdiction; generally, patients with infrequent VVS with clear prodrome can drive; those with recurrent unpredictable syncope should avoid driving until controlled
- Avoid high-risk occupations/activities (heights, heavy machinery) during active recurrence
- Hydration, salt intake, and counter-pressure maneuvers are the cornerstone of prevention
Expected recovery: Most patients with VVS have a benign course with spontaneous remission. Recurrence rates vary but decrease with trigger avoidance and lifestyle modifications. [1][3]
References
1. 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. — Shen WK, Sheldon RS, Benditt DG, et al. Journal of the American College of Cardiology. 2017.
2. 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. — Shen WK, Sheldon RS, Benditt DG, et al. Journal of the American College of Cardiology. 2017.
3. 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. — Shen WK, Sheldon RS, Benditt DG, et al. Journal of the American College of Cardiology. 2017.
4. Did This Patient Have Cardiac Syncope?The Rational Clinical Examination Systematic Review. — Albassam OT, Redelmeier RJ, Shadowitz S, et al. The Journal of the American Medical Association. 2019.
5. Did This Patient Have Cardiac Syncope?The Rational Clinical Examination Systematic Review. — Albassam OT, Redelmeier RJ, Shadowitz S, et al. The Journal of the American Medical Association. 2019.
6. 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. — Writing Committee Members, Shen WK, Sheldon RS, et al. Heart Rhythm. 2017.
7. 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. — Writing Committee Members, Shen WK, Sheldon RS, et al. Heart Rhythm. 2017.
8. New Concepts in the Assessment of Syncope. — Brignole M, Hamdan MH. Journal of the American College of Cardiology. 2012.
9. New Concepts in the Assessment of Syncope. — Brignole M, Hamdan MH. Journal of the American College of Cardiology. 2012.
10. Syncope: Evaluation and Differential Diagnosis. — Bayard M, Gerayli F, Holt J. American Family Physician. 2023.
11. Syncope: Evaluation and Differential Diagnosis. — Bayard M, Gerayli F, Holt J. American Family Physician. 2023.
12. Update to Practice Standards for Electrocardiographic Monitoring in Hospital Settings: A Scientific Statement From the American Heart Association. — Sandau KE, Funk M, Auerbach A, et al. Circulation. 2017.
13. Update to Practice Standards for Electrocardiographic Monitoring in Hospital Settings: A Scientific Statement From the American Heart Association. — Sandau KE, Funk M, Auerbach A, et al. Circulation. 2017.
14. Pharmacologic Prevention of Recurrent Vasovagal Syncope: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials. — Behnoush AH, Yazdani K, Khalaji A, et al. Heart Rhythm. 2023.
15. Pharmacologic Prevention of Recurrent Vasovagal Syncope: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials. — Behnoush AH, Yazdani K, Khalaji A, et al. Heart Rhythm. 2023.
16. ACC/AHA/HRS Versus ESC Guidelines For the Diagnosis and Management Of Syncope: JACC Guideline Comparison. — Goldberger ZD, Petek BJ, Brignole M, et al. Journal of the American College of Cardiology. 2019.
17. ACC/AHA/HRS Versus ESC Guidelines For the Diagnosis and Management Of Syncope: JACC Guideline Comparison. — Goldberger ZD, Petek BJ, Brignole M, et al. Journal of the American College of Cardiology. 2019.
18. Best Practices Guidelines Geriatric Trauma Management. — Alicia Mangram MD FACS, Jessica M. Berdeja MD, Christine S. Cocanour MD FACS FCCM, et al American College of Surgeons (2023). 2023.
19. Best Practices Guidelines Geriatric Trauma Management. — Alicia Mangram MD FACS, Jessica M. Berdeja MD, Christine S. Cocanour MD FACS FCCM, et al American College of Surgeons (2023). 2023.
20. Multicenter Emergency Department Validation of the Canadian Syncope Risk Score. — Thiruganasambandamoorthy V, Sivilotti MLA, Le Sage N, et al. JAMA Internal Medicine. 2020.
21. Multicenter Emergency Department Validation of the Canadian Syncope Risk Score. — Thiruganasambandamoorthy V, Sivilotti MLA, Le Sage N, et al. JAMA Internal Medicine. 2020.
22. Canadian Syncope Risk Score: A Validated Risk Stratification Tool. — Meisenheimer ES, Rogers TS, Saguil A. American Family Physician. 2021.
23. Canadian Syncope Risk Score: A Validated Risk Stratification Tool. — Meisenheimer ES, Rogers TS, Saguil A. American Family Physician. 2021.